TY - JOUR
T1 - Inosine improves gut permeability and vascular reactivity in endotoxic shock
AU - Garcia Soriano, Francisco
AU - Liaudet, Lucas
AU - Marton, Anita
AU - Haskó, György
AU - Batista Lorigados, Clara
AU - Deitch, Edwin A.
AU - Szabó, Csaba
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2001
Y1 - 2001
N2 - Objective: To investigate the effects of inosine administration on vascular reactivity, gut permeability, neutrophil accumulation and lipid peroxidation in tissues in murine endotoxin shock. Design: Randomized, prospective laboratory study. Setting: Research laboratory. Subjects: BALB/c mice 6-8 wks age. Interventions: BALB/c mice were randomly assigned to one of five groups: a) vehicle controls, which received saline intraperitoneally; b) inosine controls, which received inosine alone (100 mg/kg, ip); c) lipopolysaccharide (LPS)-treated animals, which received LPS (40 and 100 mg/kg, ip, depending on the experimental protocol); d) inosine pretreatment group, which received inosine (100 mg/kg, ip) 30 mins before LPS; and finally, e) inosine posttreatment group, which received inosine (100 mg/kg, ip) 60 mins after LPS. Measurements and Main Results: The passage of fluorescein isothiocyanate-conjugated dextran (4 kDa, FD4) was analyzed in everted gut ileal sacs incubated ex vivo as an index of gut permeability. LPS induced a significant intestinal hyperpermeability, and inosine exerted protective effects both in pre- and posttreatment regimens. Myeloperoxidase and malondialdehyde were also measured to study neutrophil accumulation and lipid peroxidation in selected tissues. Inosine, both in pre- and posttreatment regimens ameliorated the increases in myeloperoxidase and malondialdehyde in the lung and gut. LPS-treated animals showed decreased contractile and relaxant responses, and inosine pretreatment (but not posttreatment) partially improved these responses. Conclusions: Taken together, inosine has organ protective effects during shock. A significant portion of its protective action is maintained even in the posttreatment scenario.
AB - Objective: To investigate the effects of inosine administration on vascular reactivity, gut permeability, neutrophil accumulation and lipid peroxidation in tissues in murine endotoxin shock. Design: Randomized, prospective laboratory study. Setting: Research laboratory. Subjects: BALB/c mice 6-8 wks age. Interventions: BALB/c mice were randomly assigned to one of five groups: a) vehicle controls, which received saline intraperitoneally; b) inosine controls, which received inosine alone (100 mg/kg, ip); c) lipopolysaccharide (LPS)-treated animals, which received LPS (40 and 100 mg/kg, ip, depending on the experimental protocol); d) inosine pretreatment group, which received inosine (100 mg/kg, ip) 30 mins before LPS; and finally, e) inosine posttreatment group, which received inosine (100 mg/kg, ip) 60 mins after LPS. Measurements and Main Results: The passage of fluorescein isothiocyanate-conjugated dextran (4 kDa, FD4) was analyzed in everted gut ileal sacs incubated ex vivo as an index of gut permeability. LPS induced a significant intestinal hyperpermeability, and inosine exerted protective effects both in pre- and posttreatment regimens. Myeloperoxidase and malondialdehyde were also measured to study neutrophil accumulation and lipid peroxidation in selected tissues. Inosine, both in pre- and posttreatment regimens ameliorated the increases in myeloperoxidase and malondialdehyde in the lung and gut. LPS-treated animals showed decreased contractile and relaxant responses, and inosine pretreatment (but not posttreatment) partially improved these responses. Conclusions: Taken together, inosine has organ protective effects during shock. A significant portion of its protective action is maintained even in the posttreatment scenario.
KW - Endothelial
KW - Endotoxin
KW - Gut
KW - Inosine
KW - Liver
KW - Lung
KW - Malondialdehyde
KW - Myeloperoxidase
KW - Permeability
KW - Reactivity
KW - Shock
KW - Vascular
UR - http://www.scopus.com/inward/record.url?scp=0035053867&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035053867&partnerID=8YFLogxK
U2 - 10.1097/00003246-200104000-00001
DO - 10.1097/00003246-200104000-00001
M3 - Article
C2 - 11373452
AN - SCOPUS:0035053867
SN - 0090-3493
VL - 29
SP - 703
EP - 708
JO - Critical care medicine
JF - Critical care medicine
IS - 4
ER -